01 January 2009
Early onset post transplantation lymphoproliferative disorders: Analysis of international data from 5 studies
Hossein Khedmat, Saeed TaheriAnn Transplant 2009; 14(3): 74-77 :: ID: 880545
Abstract
Backgorund: Post-transplant lymphoproliferative disease (PTLD) is a major complication after solid organ transplantation and most frequently occurs during the first year post transplantation. We analyzed patient characteristics, outcome and prognostic factors for survival of transplant patients who developed post transplant lymphoproliferative disorders within one year after transplantation reported by 5 major studies worldwide.
Material/Methods: We made a comprehensive search for the available data by Pubmed and Google scholar search engines on post transplant lymphoproliferative disorders. A standard questionnaire was developed to collect data from different published studies. Finally, trustable data of a total of 5 publishes were included in the final analysis. For data analysis we used SPSS v. 13.0. Kaplan-Meier Method was used for survival analysis. P<0.05 was defined as significant.
Results: Data of 16 patients who developed PTLD during the early 12 months after transplantation (2 liver and 14 renal) were recruited from 5 studies and entered into analysis. Mean age was 41.9±16.2 years. Univariate survival analysis showed that localization of the PTLD in brain in PTLD patients induces a highly significant adverse effect on the outcome of PTLD patients (P=0.008) but not for other localizations. We aso found that involvement of the allograft (all kidney allograft) is associated with higher rate of remission (either partial or complete remission) of PTLDs after anti-cancer therapy. No associations were found regarding other variables.
Conclusions: Because of the higher incidence rate and fatal nature, early onset PTLD is of extreme relevance. Screening all renal transplant patients in the early post transplantation period for an early detection and treatment of PTLDs is crucial, particularly in patients who are more likely to develop PTLDs.
Keywords: lymphoproliferative disorder, Transplantation, early onset
In Press
18 Mar 2024 : Original article
Does Antibiotic Use Increase the Risk of Post-Transplantation Diabetes Mellitus? A Retrospective Study of R...Ann Transplant In Press; DOI: 10.12659/AOT.943282
20 Mar 2024 : Original article
Transplant Nephrectomy: A Comparative Study of Timing and Techniques in a Single InstitutionAnn Transplant In Press; DOI: 10.12659/AOT.942252
28 Mar 2024 : Original article
Association Between FEV₁ Decline Rate and Mortality in Long-Term Follow-Up of a 21-Patient Pilot Clinical T...Ann Transplant In Press; DOI: 10.12659/AOT.942823
02 Apr 2024 : Original article
Liver Transplantation from Brain-Dead Donors with Hepatitis B or C in South Korea: A 2014-2020 Korean Organ...Ann Transplant In Press; DOI: 10.12659/AOT.943588
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860